Abstract
The αβ T cell receptor (TCR) can be triggered by a class of ligands called superantigens. Enterotoxins secreted by bacteria act as superantigens by simultaneously binding to an MHC class II molecule on an antigen-presenting cell and to a TCR β-chain, thereby causing activation of the T cell. The cross-reactivity of enterotoxins with different Vβ regions can lead to stimulation of a large fraction of T cells. To understand the molecular details of TCR-enterotoxin interactions and to generate potential antagonists of these serious hyperimmune reactions, we engineered soluble TCR mutants with improved affinity for staphylococcal enterotoxin C3 (SEC3). A library of randomly mutated, single-chain TCRs (Vβ-linker-Vα) were expressed as fusions to the Aga2p protein on the surface of yeast cells. Mutants were selected by flow cytometric cell sorting with a fluorescent-labeled SEC3. Various mutations were identified, primarily in Vβ residues that are located at the TCR:SEC3 interface. The combined mutations created a remodeled SEC3-binding surface and yielded a Vβ domain with an affinity that was increased by 1000-fold (KD = 7 nM). A soluble form of this Vβ mutant was a potent inhibitor of SEC3-mediated T cell activity, suggesting that these engineered proteins may be useful as antagonists.
Original language | English (US) |
---|---|
Pages (from-to) | 1305-1315 |
Number of pages | 11 |
Journal | Journal of Molecular Biology |
Volume | 307 |
Issue number | 5 |
DOIs | |
State | Published - Apr 13 2001 |
Keywords
- Antagonists
- Directed evolution
- Staphylococcus aureus
- T cell activity
- Yeast surface display
ASJC Scopus subject areas
- Structural Biology
- Molecular Biology